See more
What is Keppra used for?from accessdata.fda.gov
KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. KEPPRA injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.
How effective is Keppra?from accessdata.fda.gov
The effectiveness of KEPPRA as adjunctive therapy (added to other antiepileptic drugs) in adults was established in three multicenter, randomized, double-blind, placebo-controlled clinical studies in patients who had refractory partial onset seizures with or without secondary generalization.The tablet formulation was used in all these studies. In these studies, 904 patients were randomized to placebo, 1000 mg, 2000 mg, or 3000 mg/day. Patients enrolled in Study 1 or Study 2 had refractory partial onset seizures for at least two years and had taken two or more classical AEDs. Patients enrolled in Study 3 had refractory partial onset seizures for at least 1 year and had taken one classical AED. At the time of the study, patients were taking a stable dose regimen of at least one and could take a maximum of two AEDs. During the baseline period, patients had to have experienced at least two partial onset seizures during each 4week period.
How much levetiracetam is in Keppra?from accessdata.fda.gov
smaller volume is required (e.g. pediatric patients), the amount of diluent should be calculated to not exceed a maximum levetiracetam concentration of 15 mg per mL of diluted solution. Consideration should also be given to the total daily fluid intake of the patient. KEPPRA injection should be administered as a 15-minute IV infusion. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). KEPPRA injection may be mixed with the following diluents and antiepileptic drugs and may be stored in polyvinyl chloride (PVC) bags. The diluted solution should not be stored for more than 4 hours at controlled room temperature [15-30⁰C (59-86⁰F)]. Diluents: Sodium chloride (0.9%) injection, USP LactatedRinger’s injection Dextrose 5% injection, USP Other Antiepileptic Drugs: Lorazepam Diazepam Valproate sodium There are no data to support the physical compatibility of KEPPRA injection with antiepileptic drugs that are not listed above. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Product with particulate matter or discoloration should not be used. Any unused portion of the KEPPRA injection vial contents should be discarded. Adults See Table 1 for the recommended preparation and administration of KEPPRA injection for adults to achieve a dose of 500 mg, 1000 mg, or 1500 mg.
How many Keppra patients are psychotic?from drugs.com
In clinical studies, 1% of Keppra-treated adult patients, 2% of Keppra-treated pediatric patients 4 to 16 years of age, and 17% of Keppra-treated pediatric patients 1 month to <4 years of age experienced psychotic symptoms, compared to 0.2%, 2%, and 5% in the corresponding age groups treated with placebo. In a controlled study that assessed the neurocognitive and behavioral effects of Keppra in pediatric patients 4 to 16 years of age, 1.6% of Keppra-treated patients experienced paranoia, compared to 0% of placebo-treated patients. In the same study, 3.1% of Keppra-treated patients experienced confusional state, compared to 0% of placebo-treated patients [see Use in Specific Populations (8.4)].
What is the saturable binding site of levetiracetam?from drugs.com
Experimental data indicate that this binding site is the synaptic vesicle protein SV2A, thought to be involved in the regulation of vesicle exocytosis. Although the molecular significance of levetiracetam binding to SV2A is not understood, levetiracetam and related analogs showed a rank order of affinity for SV2A which correlated with the potency of their antiseizure activity in audiogenic seizure-prone mice. These findings suggest that the interaction of levetiracetam with the SV2A protein may contribute to the antiepileptic mechanism of action of the drug.
Why should Keppra be withdrawn?from accessdata.fda.gov
Antiepileptic drugs, including KEPPRA, should be withdrawn gradually to minimize the potential of increased seizure frequency.
How long does it take for a rash to appear after Keppra?from accessdata.fda.gov
The median time of onset is reported to be 14 to 17 days, but cases have been reported at least four months after initiation of treatment. Recurrence of the serious skin reactions following rechallenge with KEPPRA has also been reported. KEPPRA should be discontinued at the first sign of a rash, unless the rash is clearly not drug-related. If signs or symptoms suggest SJS/TEN, use of this drug should not be resumed and alternative therapy should be considered.
How to enroll in UCB Pharma?
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call UCB Pharma program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
What is UCB Pharma?
UCB Pharma is currently a world leader in antibody research, with over thirty major research and development partners. Their operations span over forty countries, and netted over $3 billion in 2007 alone.
What is Keppra used for?
Keppra is an anti-epilleptic launched by UCB Pharma in 2006. Keppra has been approved by the FDA to treat partial-onset seizures in adults. Keppra is administered orally via a tablet, or solution.
How long is Keppra available?
Keppra Patient Assistance Program, a patient assistance program provided by UCB Pharma, offers a six month supply of Keppra at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
What is UCB financial assistance?from ucb-usa.com
UCB is committed to ensuring patients who need our medications can access them. If you are struggling with the burden of paying for your medication there are several types of financial assistance for qualified patients.
What is UCB scholarship?from ucb.com
This scholarship provides financial support for epilepsy patients or family members/caregivers who demonstrate academic and personal achievement.
Keywords relevant to Ucb Patient Assistance Program Pdf
If you believe that this page should be taken down, please follow our DMCA take down process here.
Accredited Business
Guarantees that a business meets BBB accreditation standards in the US and Canada.
TopTen Reviews
Highest customer reviews on one of the most highly-trusted product review platforms.
IMPORTANT NOTE
if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition you can contact us using the webform available here
Epilepsy Advocate
Epilepsy Advocates are people living with epilepsy and caregivers seeking the best treatment for controlling their seizures with minimal side effects.
Canine Assistants programme
Canine Assistants was founded in Alpharetta, Georgia, in 1991. This nonprofit organization is dedicated to providing service dogs to children and adults with epilepsy, physical disabilities, and other special needs.
Support of patient organisations in Europe
UCB is committed to comply with Industry self-regulated codes, including the EFPIA Code of Practice on Relationships Between the Pharmaceutical Industry and Patient Organisations.
What is UCB financial assistance?from ucb-usa.com
UCB is committed to ensuring patients who need our medications can access them. If you are struggling with the burden of paying for your medication there are several types of financial assistance for qualified patients.
What is UCB Pharma?from patientassistance.com
UCB Pharma is currently a world leader in antibody research, with over thirty major research and development partners. Their operations span over forty countries, and netted over $3 billion in 2007 alone.
What is Keppra used for?from patientassistance.com
Keppra is an anti-epilleptic launched by UCB Pharma in 2006. Keppra has been approved by the FDA to treat partial-onset seizures in adults. Keppra is administered orally via a tablet, or solution.
How long is Keppra available?from patientassistance.com
Keppra Patient Assistance Program, a patient assistance program provided by UCB Pharma, offers a six month supply of Keppra at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
How much does Keppra cost?from drugs.com
The cost for Keppra oral tablet 500 mg is around $326 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
How to take levetiracetam?from patientassistance.com
How To Use. Take this medication by mouth, usually twice daily; or take as directed by your doctor. This drug may be taken with or without food. Levetiracetam is best taken at evenly spaced intervals throughout the day to ensure a constant level of drug in the body.
Does Keppra offer coupons?from drugs.com
Keppra Coupons and Rebates. Keppra offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
How to enroll in UCB Pharma?from patientassistance.com
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call UCB Pharma program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
What is UCB Pharma?from patientassistance.com
UCB Pharma is currently a world leader in antibody research, with over thirty major research and development partners. Their operations span over forty countries, and netted over $3 billion in 2007 alone.
How much does Keppra cost?from drugs.com
The cost for Keppra oral tablet 500 mg is around $326 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Is Keppra generic?from drugs.com
A generic version of Keppra is available, see leve tiracetam prices. This Keppra price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Does Keppra XR have coupons?from drugs.com
Keppra XR Coupons and Rebates. Keppra XR offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office. There are currently no Manufacturer Promotions ...
Where do you have to be to qualify for NEUPRO?from neupro.com
To be eligible for the NEUPRO Patient Savings Program™, you must be a resident of the United States or Puerto Rico.
What is the number to call for NEUPRO?from www2.neupro.com
If you have any questions regarding the NEUPRO Patient Savings Program™ or wish to discontinue your participation, please call 1-855-841-0263 ( 8 a.m. - 8 p.m. ET, Monday – Friday).
How long does Neupro last?from patientassistance.com
Neupro Patient Assistance Program, a patient assistance program provided by UCB Pharma, offers a six month supply of Neupro at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
What is nepro used for?from www2.neupro.com
NEUPRO is a prescription medicine used to treat moderate-to-severe primary Restless Legs Syndrome.
When does the NEUPRO card expire?from www2.neupro.com
NEUPRO Patient Savings Card will expire at the end of the calendar year.
Is the NEUPRO card good for Puerto Rico?from neupro.com
Offer good only in the U.S., including Puerto Rico. This card is good for use only with a valid NEUPRO prescription consistent with the approved FDA labeling at the time the prescription is filled by the pharmacist and dispensed to the patient. The maximum annual benefit amount is $1500 per calendar year.
Where to report side effects of a prescription drug?from www2.neupro.com
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UCB, Inc. at ucbCARES ® (1-844-599-2273).